Hims & Hers Health ( HIMS -15.90%) has been a top healthcare stock to own over the past five years, soaring by around 350% ...

Discover why Hims & Hers faces steep corrections amid GLP-1 headwinds and valuation concerns, despite promising FY2024 growth ...

Share on Pinterest Hims and Roman are telemedicine brands that provide quick shipping and discreet delivery for treatments for erectile dysfunction (ED), premature ejaculation (PE), and other ...

Hims & Hers (HIMS) stock is sinking 20% today after Eli Lilly (LLY) unveiled significantly cheaper versions of its popular weight-loss drugs today. Additionally, the FDA last week hindered the ...

Shares of direct-to-consumer healthcare platform Hims & Hers (HIMS) raced 60% higher over the past week after a successful Super Bowl ad, despite lingering disappointment over its earnings report.

Hims and Hers' stock fell over 19% in after-hours trading on Monday after its CEO said the company would no longer sell compounded versions of mega-hit weight loss drugs. "We will have to start ...